KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42 | -63.2% | 23,069 | -21.6% | 0.00% | – |
| Q1 2023 | $114 | +1040.0% | 29,434 | +875.6% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 3,017 | -83.1% | 0.00% | – |
| Q3 2022 | $97,000 | +592.9% | 17,855 | +491.8% | 0.00% | – |
| Q2 2022 | $14,000 | -41.7% | 3,017 | 0.0% | 0.00% | – |
| Q1 2022 | $24,000 | +26.3% | 3,017 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | +5.6% | 3,017 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -41.9% | 3,017 | 0.0% | 0.00% | – |
| Q2 2021 | $31,000 | -3.1% | 3,017 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | -31.9% | 3,017 | 0.0% | 0.00% | – |
| Q4 2020 | $47,000 | +6.8% | 3,017 | 0.0% | 0.00% | – |
| Q3 2020 | $44,000 | -22.8% | 3,017 | 0.0% | 0.00% | – |
| Q2 2020 | $57,000 | -1.7% | 3,017 | 0.0% | 0.00% | – |
| Q1 2020 | $58,000 | +1.8% | 3,017 | 0.0% | 0.00% | – |
| Q4 2019 | $57,000 | +67.6% | 3,017 | -46.9% | 0.00% | – |
| Q2 2019 | $34,000 | +3.0% | 5,686 | 0.0% | 0.00% | – |
| Q1 2019 | $33,000 | -35.3% | 5,686 | 0.0% | 0.00% | – |
| Q4 2018 | $51,000 | -47.4% | 5,686 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | 0.0% | 5,686 | 0.0% | 0.00% | – |
| Q2 2018 | $97,000 | +340.9% | 5,686 | +242.9% | 0.00% | – |
| Q1 2018 | $22,000 | +37.5% | 1,658 | 0.0% | 0.00% | – |
| Q4 2017 | $16,000 | -11.1% | 1,658 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | +20.0% | 1,658 | 0.0% | 0.00% | – |
| Q2 2017 | $15,000 | -28.6% | 1,658 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | +31.2% | 1,658 | 0.0% | 0.00% | – |
| Q4 2016 | $16,000 | -50.0% | 1,658 | -50.0% | 0.00% | – |
| Q3 2016 | $32,000 | +190.9% | 3,316 | +100.0% | 0.00% | – |
| Q2 2016 | $11,000 | -26.7% | 1,658 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -31.8% | 1,658 | 0.0% | 0.00% | – |
| Q4 2015 | $22,000 | +22.2% | 1,658 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -60.0% | 1,658 | 0.0% | 0.00% | – |
| Q2 2015 | $45,000 | -11.8% | 1,658 | 0.0% | 0.00% | – |
| Q1 2015 | $51,000 | -17.7% | 1,658 | 0.0% | 0.00% | – |
| Q4 2014 | $62,000 | – | 1,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |